Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Cureus|May 22, 2023
Stroke Strikes in Bangladesh: Current Insights and Future DirectionsArefin Sadat, Vivek Podder, Rakesh BiswasExpert Review of Anticancer Therapy|April 30, 2026
An evaluation of avutometinib in combination with defactinib for KRAS-mutated recurrent low-grade serous ovarian cancerVivek Podder, Brian M Slomovitz, Robert L ColemanFuture Oncology (London, England)|November 5, 2025
Unmet needs and emerging therapeutics in low-grade serous ovarian carcinoma: from chemoresistance to precision medicineBrian M Slomovitz, Vivek Podder, Erin Crane, et al.BMJ Case Reports|April 3, 2019
Middle-aged man who could not afford an angioplastyVivek Podder, Amy Price, Madhava Sai Sivapuram, et al.Annals of Neurosciences|August 27, 2020
The Role of Dystrophin Gene Mutations in Neuropsychological Domains of DMD Boys: A Longitudinal StudyRahul Tyagi, Vivek Podder, Harshita Arvind, et al.Current Opinion in Obstetrics & Gynecology|January 8, 2025
State of the art endocrine treatments for patients diagnosed with endometrial cancer in 2025Fernanda B Musa, Kathleen N Moore, Vivek Podder, et al.Cureus|July 24, 2023
Large Chorioangioma in Triplets: An Uncommon OccurrenceAvin Kounsal, Divya Saini, Vivek Podder, et al.Cancers|December 17, 2024
Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive ReviewVivek Podder, Tulika Ranjan, Kim Margolin, et al.Current Neurology and Neuroscience Reports|December 3, 2024
Emerging Therapies for Brain Metastases in NSCLC, Breast Cancer, and Melanoma: A Critical ReviewVivek Podder, Tulika Ranjan, Maya Gowda, et al.Cancers|October 16, 2024
Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future DirectionsTulika Ranjan, Vivek Podder, Kim Margolin, et al.Pageof 5